David Goldstein Insider Trading $PRNB Principia Biopharma Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for David Goldstein.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of David Goldstein. David Goldstein is Chief Scientific Officer in Principia Biopharma Inc. ($PRNB).
David Goldstein in Principia Biopharma Inc.
Trading Symbol: PRNBIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of David Goldstein: Chief Scientific Officer
Holdings: 0 shares
Latest Transaction: Sep 28 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of David Goldstein in Principia Biopharma Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 28 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Option Exercise | D | 67.31 | 75,000 | 5,048,250 | 0 | |
Sep 28 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Option Exercise | D | 35.42 | 60,000 | 2,125,200 | 0 | |
Sep 28 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Option Exercise | D | 11.35 | 44,034 | 500,002 | 0 | |
Sep 28 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Option Exercise | D | 7.27 | 34,677 | 252,001 | 0 | |
Sep 28 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Option Exercise | D | 5.00 | 22,017 | 109,999 | 0 | |
Sep 28 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Option Exercise | D | 5.00 | 15,412 | 77,000 | 0 | |
Sep 28 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Option Exercise | D | 4.72 | 8,807 | 41,601 | 0 | |
Sep 28 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Option Exercise | D | 4.72 | 13,210 | 62,399 | 0 | |
Sep 28 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Option Exercise | D | 3.18 | 12,960 | 41,205 | 0 | |
Sep 28 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Sell | U | 100.00 | 31,826 | 3,182,600 | 0 | 31.8 K to 0 (-100.00 %) |
Aug 12 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Option Exercise | M | 3.18 | 3,553 | 11,296 | 12,960 | |
Aug 12 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Option Exercise | M | 3.00 | 2,447 | 7,335 | 0 | |
Aug 12 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Sell | S | 93.34 | 100 | 9,334 | 31,739 | 31.8 K to 31.7 K (-0.31 %) |
Aug 12 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Sell | S | 90.99 | 1,108 | 100,816 | 31,839 | 32.9 K to 31.8 K (-3.36 %) |
Aug 12 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Sell | S | 89.68 | 700 | 62,773 | 32,947 | 33.6 K to 32.9 K (-2.08 %) |
Aug 12 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Sell | S | 88.40 | 2,534 | 224,012 | 33,647 | 36.2 K to 33.6 K (-7.00 %) |
Aug 12 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Sell | S | 86.92 | 700 | 60,844 | 36,181 | 36.9 K to 36.2 K (-1.90 %) |
Aug 12 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Sell | S | 86.11 | 858 | 73,886 | 36,881 | 37.7 K to 36.9 K (-2.27 %) |
Aug 12 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Buy | M | 3.18 | 3,553 | 11,296 | 37,739 | 34.2 K to 37.7 K (+10.39 %) |
Aug 12 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Buy | M | 3.00 | 2,447 | 7,335 | 34,186 | 31.7 K to 34.2 K (+7.71 %) |
May 08 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Option Exercise | M | 3.00 | 6,000 | 17,986 | 2,447 | |
May 08 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Sell | S | 60.39 | 2,719 | 164,207 | 30,968 | 33.7 K to 31 K (-8.07 %) |
May 08 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Sell | S | 59.96 | 3,281 | 196,734 | 33,687 | 37 K to 33.7 K (-8.88 %) |
May 08 2020 | PRNB | Principia Biopharm ... | Goldstein David M | Chief Scientific Of ... | Buy | M | 3.00 | 6,000 | 17,986 | 36,968 | 31 K to 37 K (+19.37 %) |
Mar 05 2020 | PRNB | Principia Biopharm ... | Goldstein David | Chief Scientific Of ... | Option Exercise | A | 67.31 | 75,000 | 5,048,250 | 75,000 | |
Feb 12 2020 | PRNB | Principia Biopharm ... | Goldstein David | Chief Scientific Of ... | Option Exercise | M | 3.00 | 6,000 | 17,986 | 8,447 | |
Feb 12 2020 | PRNB | Principia Biopharm ... | Goldstein David | Chief Scientific Of ... | Sell | S | 71.11 | 5,200 | 369,779 | 30,968 | 36.2 K to 31 K (-14.38 %) |
Feb 12 2020 | PRNB | Principia Biopharm ... | Goldstein David | Chief Scientific Of ... | Sell | S | 69.53 | 800 | 55,622 | 36,168 | 37 K to 36.2 K (-2.16 %) |
Feb 12 2020 | PRNB | Principia Biopharm ... | Goldstein David | Chief Scientific Of ... | Buy | M | 3.00 | 6,000 | 17,986 | 36,968 | 31 K to 37 K (+19.37 %) |
Nov 08 2019 | PRNB | Principia Biopharm ... | Goldstein David | Chief Scientific Of ... | Option Exercise | M | 3.00 | 1,075 | 3,223 | 14,447 | |
Nov 08 2019 | PRNB | Principia Biopharm ... | Goldstein David | Chief Scientific Of ... | Option Exercise | M | 3.00 | 1,075 | 3,223 | 14,447 | |
Nov 08 2019 | PRNB | Principia Biopharm ... | Goldstein David | Chief Scientific Of ... | Option Exercise | M | 1.91 | 1,651 | 3,149 | 0 | |
Nov 08 2019 | PRNB | Principia Biopharm ... | Goldstein David | Chief Scientific Of ... | Option Exercise | M | 1.91 | 1,651 | 3,149 | 0 | |
Nov 08 2019 | PRNB | Principia Biopharm ... | Goldstein David | Chief Scientific Of ... | Option Exercise | M | 1.91 | 6,147 | 11,726 | 0 | |
Nov 08 2019 | PRNB | Principia Biopharm ... | Goldstein David | Chief Scientific Of ... | Option Exercise | M | 1.91 | 6,147 | 11,726 | 0 | |
Nov 08 2019 | PRNB | Principia Biopharm ... | Goldstein David | Chief Scientific Of ... | Option Exercise | M | 0.64 | 1,127 | 717 | 0 | |
Nov 08 2019 | PRNB | Principia Biopharm ... | Goldstein David | Chief Scientific Of ... | Option Exercise | M | 0.64 | 1,127 | 717 | 0 | |
Nov 08 2019 | PRNB | Principia Biopharm ... | Goldstein David | Chief Scientific Of ... | Sell | S | 32.39 | 10,000 | 323,914 | 29,819 | 39.8 K to 29.8 K (-25.11 %) |
Nov 08 2019 | PRNB | Principia Biopharm ... | Goldstein David | Chief Scientific Of ... | Sell | S | 32.39 | 10,000 | 323,914 | 29,819 | 39.8 K to 29.8 K (-25.11 %) |
Nov 08 2019 | PRNB | Principia Biopharm ... | Goldstein David | Chief Scientific Of ... | Buy | M | 3.00 | 1,075 | 3,223 | 39,819 | 38.7 K to 39.8 K (+2.77 %) |
Nov 08 2019 | PRNB | Principia Biopharm ... | Goldstein David | Chief Scientific Of ... | Buy | M | 3.00 | 1,075 | 3,223 | 39,819 | 38.7 K to 39.8 K (+2.77 %) |
Nov 08 2019 | PRNB | Principia Biopharm ... | Goldstein David | Chief Scientific Of ... | Buy | M | 1.91 | 1,651 | 3,149 | 38,744 | 37.1 K to 38.7 K (+4.45 %) |
Nov 08 2019 | PRNB | Principia Biopharm ... | Goldstein David | Chief Scientific Of ... | Buy | M | 1.91 | 1,651 | 3,149 | 38,744 | 37.1 K to 38.7 K (+4.45 %) |
Nov 08 2019 | PRNB | Principia Biopharm ... | Goldstein David | Chief Scientific Of ... | Buy | M | 1.91 | 6,147 | 11,726 | 37,093 | 30.9 K to 37.1 K (+19.86 %) |
Nov 08 2019 | PRNB | Principia Biopharm ... | Goldstein David | Chief Scientific Of ... | Buy | M | 1.91 | 6,147 | 11,726 | 37,093 | 30.9 K to 37.1 K (+19.86 %) |
Nov 08 2019 | PRNB | Principia Biopharm ... | Goldstein David | Chief Scientific Of ... | Buy | M | 0.64 | 1,127 | 717 | 30,946 | 29.8 K to 30.9 K (+3.78 %) |
Nov 08 2019 | PRNB | Principia Biopharm ... | Goldstein David | Chief Scientific Of ... | Buy | M | 0.64 | 1,127 | 717 | 30,946 | 29.8 K to 30.9 K (+3.78 %) |
Mar 08 2019 | PRNB | Principia Biopharm ... | Goldstein David | Chief Scientific Of ... | Option Exercise | A | 35.42 | 60,000 | 2,125,200 | 60,000 |
Page: 1